Detailed information for compound 1529919

Basic information

Technical information
  • TDR Targets ID: 1529919
  • Name: 4-piperidin-1-ylsulfonylthiophene-2-carboxami de
  • MW: 274.36 | Formula: C10H14N2O3S2
  • H donors: 1 H acceptors: 3 LogP: 0.81 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: NC(=O)c1scc(c1)S(=O)(=O)N1CCCCC1
  • InChi: 1S/C10H14N2O3S2/c11-10(13)9-6-8(7-16-9)17(14,15)12-4-2-1-3-5-12/h6-7H,1-5H2,(H2,11,13)
  • InChiKey: OEVNTVLFHHGVFH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-(1-piperidylsulfonyl)thiophene-2-carboxamide
  • 4-(1-piperidylsulfonyl)-2-thiophenecarboxamide
  • 4-piperidinosulfonylthiophene-2-carboxamide
  • 4-(Piperidine-1-sulfonyl)-thiophene-2-carboxylic acid amide
  • BAS 15757593
  • ZINC06678594
  • E557-0203
  • NCGC00122735-01

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) brahma associated protein 0.0034 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0034 1 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0034 1 1
Brugia malayi brahma associated protein 60 kDa 0.0034 1 1
Chlamydia trachomatis SWIB complex protein 0.0034 1 0.5
Brugia malayi SWIB/MDM2 domain containing protein 0.0034 1 1
Leishmania major hypothetical protein, conserved 0.003 0.7544 0.5
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0034 1 0.5
Schistosoma mansoni hypothetical protein 0.0034 1 0.5
Schistosoma mansoni hypothetical protein 0.0034 1 0.5
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0034 1 1
Schistosoma mansoni hypothetical protein 0.0034 1 0.5
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0034 1 1
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0034 1 1
Echinococcus granulosus SWI:SNF matrix associated 0.0034 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0034 1 0.5
Schistosoma mansoni brg-1 associated factor 0.0034 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0034 1 0.5
Brugia malayi hypothetical protein 0.003 0.7544 0.7544
Onchocerca volvulus 0.0034 1 0.5
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0034 1 0.5
Chlamydia trachomatis DNA topoisomerase I 0.0034 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0034 1 0.5
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.7544 0.5
Plasmodium vivax hypothetical protein, conserved 0.0034 1 1
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0034 1 1
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.7544 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.7544 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0034 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 1 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.